AJP - Heart BIOPAC complete lab solutions
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol (June 10, 2004). doi:10.1152/ajpheart.00416.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/5/H2364    most recent
00416.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, J.
Right arrow Articles by Vondriska, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, J.
Right arrow Articles by Vondriska, T. M.
Submitted on May 10, 2004
Accepted on June 1, 2004

Bmx, a member of the Tec family of non-receptor tyrosine kinases, is a novel participant in pharmacological cardioprotection

Jun Zhang1, Peipei Ping1, Guang-wu Wang1, Ming Lu1, Dawn Pantaleon1, Xian-Liang Tang2, Roberto Bolli2, and Thomas M. Vondriska1*

1 Department of Physiology and Medicine/Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
2 Division of Cardiology, University of Louisville, Louisville, KY, USA

* To whom correspondence should be addressed. E-mail: tvondriska{at}mednet.ucla.edu.

Previous studies have indicated that PKC{epsilon} is a central regulator of protective signal transduction in the heart. However, the signaling modules through which PKC{epsilon} exerts its protective effects have only begun to be understood. We have identified a novel participant in the PKC{epsilon} signaling system in cardioprotection, the non-receptor tyrosine kinase Bmx. Functional proteomic analyses of PKC{epsilon} signaling complexes identified Bmx as a member of these complexes. Subsequent studies in rabbits have indicated that Bmx is activated by nitric oxide (NO) in the heart concomitant with the late phase of NO donor-induced protection and provide the first analysis of Bmx expression/distribution in the setting of cardioprotection. In addition, increased expression of Bmx induced by NO donors was blocked by the same mechanism that blocked cardioprotection: inhibition of PKC with chelerythrine. These findings indicate that a novel type of PKC-tyrosine kinase module (involving Bmx) is formed in the heart and may be involved in pharmacological cardioprotection by NO donors.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
T. Tu, D. Thotala, L. Geng, D. E. Hallahan, and C. D. Willey
Bone Marrow X Kinase-Mediated Signal Transduction in Irradiated Vascular Endothelium
Cancer Res., April 15, 2008; 68(8): 2861 - 2869.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
C. H. Chau, C. A. Clavijo, H.-T. Deng, Q. Zhang, K.-J. Kim, Y. Qiu, A. D. Le, and D. K. Ann
Etk/Bmx mediates expression of stress-induced adaptive genes VEGF, PAI-1, and iNOS via multiple signaling cascades in different cell systems
Am J Physiol Cell Physiol, August 1, 2005; 289(2): C444 - C454.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
P. Mathur, S. Kaga, L. Zhan, D. K. Das, and N. Maulik
Potential candidates for ischemic preconditioning-associated vascular growth pathways revealed by antibody array
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H3006 - H3010.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.